5 assets in Pulmonary Embolism

Therapeutic assets addressing Pulmonary Embolism, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Apixaban Pulmonary Embolism	Medical University of Gdansk	P3	BB (68)
Enoxaparin Pulmonary Embolism	Medical University of Gdansk	P1/2	B (60)
Edoxaban Pulmonary Embolism	Humanis Saglık Anonim Sirketi	N/A	D (30)
Edoxaban [Lixiana] Pulmonary Embolism	Humanis Saglık Anonim Sirketi	N/A	D (30)
Rivaroxaban Pulmonary Embolism	Medical University of Gdansk	N/A	D (30)